Predicting Tumor Responses to Gefitinib and Erlotinib

समान संसाधन

• Correction: Predicting Tumor Responses to Gefitinib and Erlotinib
  प्रकाशित: (2012)
• Volumetric tumor response and progression in EGFR-mutant NSCLC patients treated with erlotinib or gefitinib
  द्वारा: Nishino, Mizuki, और अन्य
  प्रकाशित: (2016)
• Enhanced antiproliferative and apoptotic response to combined treatment of γ-tocotrienol with erlotinib or gefitinib in mammary tumor cells
  द्वारा: Bachawal, Sunitha V, और अन्य
  प्रकाशित: (2010)
• Morphologic Features of Adenocarcinoma of the Lung Predictive of Response to the Epidermal Growth Factor Receptor Kinase Inhibitors Erlotinib and Gefitinib
  द्वारा: Zakowski, Maureen F., और अन्य
  प्रकाशित: (2009)
• KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib
  द्वारा: Pao, William, और अन्य
  प्रकाशित: (2005)